X

Trial Profile

The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 03 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sulodexide (Primary)
Indications Diabetic nephropathies
Focus Therapeutic Use
Acronyms SUN-MICRO
Sponsors Keryx Biopharmaceuticals

Most Recent Events

07 Mar 2008 Primary endpoint not met: results announced by Keryx.
11 Feb 2008 Status changed to completed in accordance with media release 9085123.
05 Dec 2007 A review by the Data Safety Monitoring Committee found no reason to recommend alteration or termination of the trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com